Wattacheril J. Nonalcoholic steatohepatitis (NASH): Diagnosis, treatment, and implications.Clin Liver Dis. 2018;22(1):1-10. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease.J Clin Endo...
10. Saponaro, F., Sestito, S., Runfola, M., Rapposelli, S. & Chiellini, G. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders. Frontiers ...
非酒精性脂肪性肝病(nonalcoholic fatty liver disease, NAFLD)是目前最常见的慢性肝病之一,指除酒精和其他对肝脏有明确损害因素所引起的,肝脏内脂质过度沉积的疾病,包括单纯性脂肪肝(nonalcoholic fatty liver, NAFL)、非酒精性脂肪性肝炎(nonalcoholic steatohepatitis, NASH)及相关肝硬化。其中,NASH是NAFLD恶化的关键...
Wattacheril J. Nonalcoholic steatohepatitis (NASH): Diagnosis, treatment, and implications. Clin Liver Dis. 2018;22(1):1-10. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab. 2008;93(11_suppl_1). Lee Y, Kim JW, Nyasae M...
10. Saponaro, F., Sestito, S., Runfola, M., Rapposelli, S. & Chiellini, G. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders. Frontiers in Medicine vol. 7 Preprint at https://doi.org/10.3389/fmed....
[1]LAVINE JE,SCHWIMMER JB,van NATTA ML,et al. Effect of vitamin E or metformin for treatment ofnonalcoholic fatty liver disease in children and adolescents: The TONICrandomized controlled trial[J]. JAMA,2011,305( 16) : 1659 -1668.
Liver Disease Quiz IQ What Are Treatment Options for Fatty Liver Disease? The treatment of fatty liver disease is to decrease the potential risk exposures to the liver. Avoiding alcohol:For those with alcoholic liver disease, abstaining from alcohol is a must. ...
Treatment of NASH: nutritional counseling and physical exercise. Nippon Rinsho 2006;64(6):1139-45.Yoneda M,Fujita K,Iwasaki T,Maeyama S,Terauchi Y,Nakajima A.Treatment of NASH: nutritional counseling and physical exercise.Japanese Journal of Clinical Medicine. 2006...
1.Stefan N, et al. Non-alcoholic fatty liver disease: causes,diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol, 2019. 2.非酒精性脂肪性肝病防治指南(2018年更新版). 实用肝脏病杂志. 2018. 3.Xu FY, et al. Genome Sequencing of Chromosome 1 Substitution Lin...
Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress（来源：Arrowhead）[2] Abul-Husn, NS et al. A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease. The New England journal of medicine (2018)